Cargando…
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
BACKGROUND: Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone treatment on patients with persistent olfactory disorders after COVID-19. METHODS: We performed a randomiz...
Autores principales: | Schepens, Emma J. A., Blijleven, Esther E., Boek, Wilbert M., Boesveldt, Sanne, Stokroos, Robert J., Stegeman, Inge, Kamalski, Digna M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667850/ https://www.ncbi.nlm.nih.gov/pubmed/36384737 http://dx.doi.org/10.1186/s12916-022-02625-5 |
Ejemplares similares
-
Correction: Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
por: Schepens, Emma J. A., et al.
Publicado: (2023) -
COCOS trial: COrticosteroids for COVID-19-induced loss of Smell–protocol for a single-centred, double-blind, randomised, placebo-controlled trial
por: Schepens, Emma J A, et al.
Publicado: (2022) -
A Comparative Analysis of the Incidence, Severity and Duration of Smell and Taste Loss in COVID-19 Cases Versus Non-COVID-19 Cases: A Longitudinal Cohort Study
por: Schepens, Emma J. A., et al.
Publicado: (2023) -
The impact of injury of the chorda tympani nerve during primary stapes surgery or cochlear implantation on taste function, quality of life and food preferences: A study protocol for a double-blind prospective prognostic association study
por: Blijleven, Esther E., et al.
Publicado: (2023) -
The potential for clinical application of automatic quantification of olfactory bulb volume in MRI scans using convolutional neural networks
por: Postma, Elbrich M., et al.
Publicado: (2023)